White Paper

Crossing The Chasm: Real-World Value Realized From DHTs In Clinical Trials

Source: ActiGraph
getty-155277133-storytelling-data-paper-digital

Digital health technologies (DHTs) are transforming drug development by overcoming key limitations in clinical trials, with growing evidence supporting their value and usability. DHTs can enhance study design, improving the likelihood of detecting treatment effects while reducing trial size and duration. Explore four real-world examples of clinical trials that successfully integrated DHTs. Each case study highlights how DHTs impacted specific aspects of trial design, offering practical insights into the tangible benefits for sponsors. From tracking physical activity in rare diseases to assessing sleep patterns in sleep disorder studies, these examples demonstrate the power of DHTs to streamline research and unlock new possibilities in clinical investigations.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader